Tg Therapeutics Inc (TGTX) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Tg Therapeutics Inc   (NASDAQ: TGTX)
 

Tg Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TGTX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 60.74 % 14.14 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 8.16 % -1.07 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 68.78 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 12.29 % 2.69 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 426.73 % 7.52 % 8.67 % 13.63 %


TGTX's Growth Comparisons in III. Quarter 2026




Strong but slowing Revenue rise by Tg Therapeutics Inc of 60.74% year on year , in the third quarter 2026 to 260 millions, was higher than the 14.14% rise in the Major Pharmaceutical Preparations industry, and 10.18% improvement in the Healthcare sector. Comparing the third quarter sales growth, both Major Pharmaceutical Preparations industry and Tg Therapeutics Inc outperformed 10.9% overall market increase.

Comparing the company's Revenue to the second quarter results, sales were higher by 8.16% . On the yearly basis, average annual sales growth for Tg Therapeutics Inc is 426.73%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

TGTX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
68.24 %
-
Product Neuraxpharm
-
-
Product UNITED STATES
-
-
License Revenue
200.58 %
-
Total
69.56 %
-66.75 %


Growth Rates of TGTX's Income in the third quarter 2026


TGTX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 192.52 % 4.19 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) 296.32 % -23.95 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) 87.65 % 30.78 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 41.47 % -2.24 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change - 14.12 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -85.81 % -16.85 % -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 612.8 % -26.31 % -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -76.3 % 6.26 % 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -75.98 % -9.98 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 14.58 % 8.91 % -28.64 %

TGTX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -85.81 % -17.47 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) 612.8 % 21.94 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) -76.3 % 5.06 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) -75.98 % -10.2 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth - 14.14 % 9.08 % 23.95 %

TGTX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -85.5 % -31.09 % -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 680 % -35.27 % -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -75.9 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -75.66 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -0.46 % 8.91 % -28.64 %



TGTX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -85.6 % -31.6 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) 600 % 7.1 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -75.79 % 0.05 % 10.63 % 4.93 %
EPS Net 5 Year Avg. Change - 14.14 % 9.08 % 23.95 %



As Tg Therapeutics Inc 's income per share faded by -85.6% year on year in the third quarter, Major Pharmaceutical Preparations industry fell only by -31.6%, Tg Therapeutics Inc 's third quarter performance was trailing Major Pharmaceutical Preparations, and underperformed the -39.2% EPS slide in the Healthcare sector. Weak third quarter income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Tg Therapeutics Inc results which underperformed overall market.

The Company's sequential EPS growth rate was very impressive 600% from the second quarter. Average yearly income per share growth for Tg Therapeutics Inc is 426.73%, while S & P 500's average annual income per share growth is 23.95% over the five years, including only Businesses with the third quarter 2026 earnings results.

TGTX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 25.56 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 15.33 % -29.98 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) - 12.44 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) 392.17 % 3.57 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 0.89 % 0.42 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.88 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 252.5 % 18.43 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) -3.75 % -21.14 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 312.5 % 15.58 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 41.14 % 1.87 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change -9.73 % 7.84 % 8.61 % 14.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.